Skip to content

The stability of the periosteal vertical mattress suture technique for maxillary augmentation: a retrospective study

The stability of the periosteal vertical mattress suture technique for maxillary augmentation: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091474
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

jawbone deficiency

Interventions

GBR combined with PVMS technology group:None
GBR group:None

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient has a bone defect with at least one tooth position; 2. The patient underwent CT scans before bone grafting, immediately after surgery, and 6 months after surgery; 3. The bone filling material used by the patient during the surgery is deproteinized bovine bone mineral (Bio Oss, Geistlich, Switzerland), the surface covering material is absorbable collagen barrier membrane (Bio Gide, Geistlich, Switzerland), and the suture material is 4-0 absorbable suture (Coated VICRYL, Ethicon, USA); 4. The patient's bone defect is located in the upper jaw.

Exclusion criteria

Exclusion criteria: 1. Serious systemic diseases, such as uncontrolled diabetes, serious heart disease and autoimmune diseases; 2. Patients who smoke more than 10 cigarettes per day; 3. Postoperative lost to follow-up patients; 4. Within 6 months before and after surgery, non steroidal anti-inflammatory drugs, corticosteroids, and tetracycline were taken individuals who use antibiotics, bisphosphonates, or other drugs that affect bone regeneration; 5. There are systemic or local bone diseases, such as tuberculosis, osteoarthritis, bone tumors, osteosclerosis, osteomalacia, severe osteoporosis, etc.

Design outcomes

Primary

MeasureTime frame
Bone width;

Secondary

MeasureTime frame
Incidence of complications;Bone volume;

Countries

China

Contacts

Public ContactJianping Chen

Zhejiang Provincial People's Hospital

1522643060@qq.com+86 159 0664 4221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026